摘要
目的:了解药品集中带量采购领域的研究现状,为今后相关领域的研究热点与前沿提供参考。方法:系统检索2016年1月至2022年8月万方数据库、中国知网、中国生物医学文献数据库中关于药品集中带量采购的相关文献,应用Endnote X9软件,从年度发文数量、期刊分布、发文机构分布等方面进行统计分析;运用VOSviewer 1.6.18软件进行高频关键词分析、关键词共现聚类分析、关键词共现时间线分析,并对知识图谱进行可视化展示。结果:药品集中带量采购研究的文献总体发表数量呈逐年增长趋势,其中《中国医疗保险》《卫生经济研究》和《中国药房》等期刊发表的该主题文献较多。研究热点以政策的实施效果分析、日均费用、药品临床应用经济性评价等为主。结论:药品集中带量采购政策在医疗机构药事管理中日益完善,新的带量品种从化学药拓展到生物药,为后续其他药品实施专项采购提供借鉴。
OBJECTIVE:To investigate the research status of centralized drug procurement policy,so as to provide reference for the research hot spots and frontiers in related fields in the future.METHODS:From Jan.2016 to Aug.2022,relevant literature on centralized drug procurement was systematically retrieved from Wanfang Data,CNKI and CBM.Endnote X9 was used to statistically analyze the annual number of publications,distribution of journal,and distribution of publishing institutions.VOSviewer 1.6.18 software was adopted for high-frequency keywords analysis,network analysis of keyword co-occurrence,timeline view of keyword co-occurrence network,and knowledge graph was displayed visually.RESULTS:The number of publications of the research on centralized drug procurement showed an increasing trend year by year,with more literature on this topic published in journals such as China Medical Insurance,Health Economic Research and China Pharmacy.The main research hot spots were the analysis of policy implementation effect,average daily cost and economic evaluation of clinical drug use.CONCLUSIONS:The centralized drug procurement policy has been increasingly improved in the pharmaceutical management of medical institutions,and the new varieties of drug procurement have been expanded from chemical drugs to biological drugs,providing reference for the follow-up implementation of special procurement of other drugs.and in-depth research can be performed by exploring information management and medical insurance incentive measures.
作者
陈井霞
陈万生
王卓
王学彬
CHEN Jingxia;CHEN Wansheng;WANG Zhuo;WANG Xuebin(Dept.of Pharmacy,the First Affiliated Hospital,Naval Medical University,Shanghai 200433,China;Dept.of Pharmacy,the Second Affiliated Hospital,Naval Medical University,Shanghai 200003,China)
出处
《中国医院用药评价与分析》
2023年第10期1268-1272,共5页
Evaluation and Analysis of Drug-use in Hospitals of China
基金
上海市药学会“药品临床综合评价与药物治疗路径”研究项目(No.SHYXH-ZP-2021-01)。
